The Week That Was, The Week Ahead: Macro and Markets, October 25
U.S. stocks finished Friday lower as rising oil prices and renewed inflation concerns weighed on Wall Street. The Dow Jones Industrial Average (DJI...
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 24,270 | $28,081,987 | -1% | 4.03% |
| 2. | Lee Munder Capital Group Lee Munder | 20,080 | $23,234,166 | -2% | 1.25% |
| 3. | Bailard Inc Thomas Bailard | 13,770 | $15,933,215 | +2% | 0.32% |
| 4. | Ayrshire Capital Management John Nevin Jr. | 6,440 | $7,451,491 | -3% | 3.41% |
| 5. | Sivik Global Healthcare Krishen Sud | 4,230 | $4,894,448 | -16% | 2.8% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,175.10 | 6,500 | $7,638,150.00 | 54,147 | 2026-08-17 | Filing | |
| $1,185.01 | 2,000 | $2,370,020.00 | 1,526 | 2026-08-10 | Filing | |
| $1,190.00 | 5,000 | $5,950,000.00 | 11,875 | 2026-08-07 | Filing | |
| $1,150.77 | 2,500 | $2,876,925.00 | 29,804 | 2026-06-10 | Filing | |
| $996.18 | 2,208 | $2,199,572.06 | 91,881,150 | 2026-05-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 90,066,978 | $104,214,698,904 | 100% | |
| 2. | 1,478,787 | $1,711,074,659 | 23.01% | |
| 3. | 833,498 | $964,423,867 | 1.16% | |
| 4. | 784,936 | $908,233,747 | 0.88% | |
| 5. | 605,569 | $700,691,778 | 13.83% |
News See All
Polen Focus Growth Strategy Trims Eli Lilly and Company (LLY) While Maintaining Confidence in Its Outlook
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” Q3 2026 investor letter. A copy of the letter can be downloaded here.
Eli Lilly (LLY) Grew Revenue 48% While Prices Fell, Can Volume Keep Winning?
Eli Lilly (NYSE:LLY) reports third-quarter results in about a week, and the split between volume and price matters more than the headline total.
Novo Nordisk Stock (NVO) Climbs 2% Today on Positive CagriSema Weight-Loss Data
Novo Nordisk stock gained on Tuesday alongside new weight-loss data from women who used CagriSema.
Eli Lilly Stock (LLY) Hits All-Time High Ahead of Earnings
The pharma giant reports financial results on Oct. 29.
Bristol Myers vs. Eli Lilly: Is BMY’s Deep Valuation Discount Hiding an Opportunity?
Bristol-Myers Squibb Company (NYSE:BMY) and Eli Lilly and Company (NYSE:LLY) are almost opposites in the pharmaceutical market.
10 Best Big Name Stocks to Buy According to Financial Media
Wall Street has had a remarkable run in 2026, but the latest market turbulence is a reminder of how quickly investor sentiment can change.
Can Eli Lilly's Growth Keep Justifying its Premium?
Eli Lilly and Company (NYSE:LLY) has delivered the kind of growth that helps explain why investors are willing to pay a premium for its shares.
10 Best Stocks to Buy for the Next 20 Years
Buying a stock for the next 20 years requires looking beyond the next earnings report or market rally.
Can Eli Lilly's (LLY) Growth Machine Keep Delivering?
Eli Lilly and Company (NYSE:LLY) has returned 36.37% over the last six months, as of October 15.
Hedge Fund Resource Center